D

Taysha Gene Therapies, Inc. TSHA

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$3.97$4.18
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Revenue -- -- -- 5.49M --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- 5.49M --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- 5.49M --
SG&A Expenses 13.11M 12.15M 9.68M 8.83M 8.28M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 41.87M 50.78M 43.49M 33.79M 34.02M
Operating Income -41.87M -50.78M -43.49M -28.30M -34.02M
Income Before Tax -39.13M -46.64M -42.41M -27.85M -32.73M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -39.13M -46.64M -42.41M -27.85M -32.73M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -39.13M -46.64M -42.41M -27.85M -32.73M
EBIT -41.87M -50.78M -43.49M -28.30M -34.02M
EBITDA -41.62M -50.49M -43.19M -28.00M -33.74M
EPS Basic -0.10 -0.13 -0.12 -0.08 -0.09
Normalized Basic EPS -0.06 -0.08 -0.07 -0.05 -0.06
EPS Diluted -0.10 -0.13 -0.12 -0.08 -0.09
Normalized Diluted EPS -0.06 -0.08 -0.07 -0.05 -0.06
Average Basic Shares Outstanding 406.11M 369.04M 366.63M 357.32M 353.31M
Average Diluted Shares Outstanding 406.11M 369.04M 366.63M 357.32M 353.31M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --